Allspring Global Investments’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Allspring Global Investments's PTCT Position: Q2 2026 in Review
Allspring Global Investments reduced its PTC Therapeutics (PTCT) stake by 17% in Q2 2026, selling an estimated $604K and leaving 39,501 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #982.
Allspring Global Investments first reported a position in PTCT in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.29M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Allspring Global Investments held 39,501 shares of PTC Therapeutics worth $3.21M as of Q2 2026.
- Allspring Global Investments sold 8,370 PTC Therapeutics shares in Q2 2026, an estimated $604K.
- PTC Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #982 holding.
- Allspring Global Investments first reported a position in PTC Therapeutics in Q4 2021 and has held it in 17 quarters since.
- Allspring Global Investments's PTC Therapeutics position peaked at $3.29M in Q1 2026.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.